Deadline: 01-Sep-2026
The BrightFocus Foundation is accepting applications for its FY27 Standard Funding Program in Alzheimer’s Disease Research to support innovative scientific studies that advance understanding, prevention, diagnosis, and treatment of Alzheimer’s disease and related dementias (ADRD). The program supports both early-career and established investigators conducting high-impact research with the potential to accelerate progress in the fight against neurodegenerative diseases.
Through this funding opportunity, researchers can pursue novel ideas, high-risk and high-reward studies, and cross-disciplinary approaches that contribute to meaningful advances in Alzheimer’s disease research. The program also promotes scientific rigor, transparency, data sharing, and reproducibility to strengthen research quality and impact.
About the Program
The FY27 Standard Funding Program is designed to support innovative and scientifically rigorous research focused on Alzheimer’s disease and related dementias.
The program encourages research in:
- Alzheimer’s disease and related dementias (ADRD)
- Disease etiology and mechanisms
- Prevention strategies
- Therapeutic development
- Diagnosis and early detection
- Translational research
- Preclinical and clinical studies
- Biomarker development
- Data-driven research approaches
- Cross-disciplinary scientific innovation
The initiative supports projects that have the potential to generate significant advances in scientific knowledge and improve outcomes for individuals affected by Alzheimer’s disease and related disorders.
Funding Tracks
The program is divided into two distinct funding tracks to support researchers at different career stages.
Early Career Track
The Early Career Track supports investigators who are building independent research careers.
Applicants must:
- Be within 15 years of receiving an MD, PhD, or equivalent degree
- Hold a position that allows independent research
- Have the ability to manage research grants independently
- Demonstrate strong potential for scientific leadership and innovation
The track aims to help emerging researchers establish competitive research programs in Alzheimer’s disease and dementia research.
Independent Investigator Track
The Independent Investigator Track supports highly competitive research projects with strong innovation potential.
The track is intended for researchers pursuing ambitious projects that can significantly advance understanding of Alzheimer’s disease and related dementias.
Researchers from a wide range of disciplines are encouraged to apply, including:
- Neuroscience
- Engineering
- Artificial intelligence
- Machine learning
- Physics
- Cancer biology
- Computational sciences
- Biomedical sciences
- Translational medicine
The program particularly welcomes novel perspectives and interdisciplinary approaches that can address complex challenges in dementia research.
Funding Information
The award provides:
- Up to $100,000 per year
- Maximum project duration of three years
- Total funding of up to $300,000
Project start date:
- July 1, 2027
Funding is intended to support innovative research activities that contribute directly to Alzheimer’s disease and related dementias research objectives.
Eligible Applicants
Applications are welcomed from researchers affiliated with:
- Academic institutions
- Universities
- Nonprofit research organizations
- Government research institutions
- For-profit research organizations
- Biotechnology companies
- Startup organizations
- Medical research centers
The program encourages participation from both Alzheimer’s specialists and researchers from other scientific disciplines whose expertise may contribute new insights into ADRD research.
Research Priorities
The program supports projects that demonstrate:
- Scientific innovation
- Strong research significance
- Potential for high impact
- Rigorous experimental design
- Clear relevance to ADRD
- Novel methodologies and approaches
- Cross-disciplinary collaboration
- Reproducibility and transparency
Projects should contribute to improving the understanding, diagnosis, prevention, or treatment of Alzheimer’s disease and related dementias.
Application Requirements
Applicants are required to submit a comprehensive research proposal through the official online application system.
Application materials typically include:
- Detailed research plan
- Specific aims
- Technical research summary
- Non-technical summary
- Budget and budget justification
- Data sharing plan
- Benchmark accomplishments and milestones
- Institutional approvals and certifications
- Letters or documentation from collaborators
- Supporting institutional information
Applications should clearly demonstrate scientific merit, feasibility, innovation, and potential impact.
Review and Selection Process
Applications are evaluated through a peer-review process conducted by scientific review committees.
Review panels consist of:
- Established researchers
- Scientific experts
- Subject-matter specialists
- Leaders in relevant research fields
Evaluation criteria include:
- Significance of the proposed research
- Innovation and originality
- Research methodology and approach
- Investigator qualifications
- Institutional facilities and environment
- Budget justification
- Likelihood of advancing the field
Only the most competitive proposals demonstrating strong scientific value and impact potential will be selected for funding.
Research Ethics and Compliance
Research involving human participants or vertebrate animals must comply with all relevant institutional and federal regulations.
Applicants are expected to demonstrate:
- Ethical research practices
- Regulatory compliance
- Appropriate approvals and oversight
- Protection of human participants
- Responsible animal research practices
Compliance documentation may be required as part of the award process.
Commitment to Open Science
BrightFocus emphasizes research practices that improve scientific quality and credibility.
Key principles include:
- Transparency in research
- Data sharing
- Reproducibility
- Rigorous methodology
- Open scientific practices
- Responsible reporting of findings
These principles are intended to accelerate scientific progress and maximize the impact of funded research.
Why This Program Matters
Alzheimer’s disease and related dementias remain among the most significant global health challenges, affecting millions of individuals and families worldwide. Continued scientific innovation is essential for improving diagnosis, identifying effective treatments, and advancing prevention strategies.
The BrightFocus Foundation FY27 Standard Funding Program provides critical support for researchers pursuing transformative ideas and breakthrough discoveries. By investing in both emerging and established investigators, the program helps drive progress toward a deeper understanding of ADRD and the development of solutions that can improve patient outcomes and quality of life.
Frequently Asked Questions
Who can apply for the FY27 Standard Funding Program?
- Researchers affiliated with academic, nonprofit, governmental, biotechnology, startup, and other eligible research institutions may apply.
What is the maximum funding available?
- Applicants may receive up to $100,000 per year for up to three years, totaling a maximum award of $300,000.
What are the two funding tracks?
- The program includes the Early Career Track and the Independent Investigator Track.
Who is eligible for the Early Career Track?
- Investigators within 15 years of earning an MD, PhD, or equivalent degree who hold positions allowing independent research and grant management.
Can researchers from outside the Alzheimer’s field apply?
- Yes. Researchers from disciplines such as artificial intelligence, engineering, machine learning, physics, and cancer biology are encouraged to apply under the Independent Investigator Track.
How are applications evaluated?
- Applications undergo peer review and are assessed based on significance, innovation, research approach, investigator qualifications, facilities, and budget justification.
When will funded projects begin?
- Approved projects are expected to begin on July 1, 2027.
Conclusion
The BrightFocus Foundation FY27 Standard Funding Program offers substantial support for innovative Alzheimer’s disease and related dementias research. Through funding of up to $300,000, the program empowers early-career and established investigators to pursue groundbreaking research, foster scientific innovation, and contribute to the development of new strategies for understanding, preventing, diagnosing, and treating ADRD.
For more information, visit BrightFocus Foundation.